Genomic Health Q4 Revenues Climb 14 Percent as It Targets Prostate Cancer, International Markets for Growth | GenomeWeb

NEW YORK (GenomeWeb News) – Genomic Health said after the close of the market on Tuesday that its revenues in the fourth quarter increased 14 percent year over year.

Total revenues for the three months ended Dec. 31, 2013 came in at $68.8 million, up from $60.4 million, but short of the average analyst estimate of $69.2 million. Product revenues rose 12 percent to $67.1 million from $60 million, while contract revenues rose more than four-fold to $1.8 million from $429,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.